TradingView
RocketTickers
Apr 23, 2021 7:02 PM
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Ca
Long
NASDAQ:ANAB
60
AnaptysBio, Inc.
NASDAQ
Description
⋅
Apr 23, 2021 7:02 PM
ANAB: AnaptysBio, Inc.
2021-04-22 16:12:09
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
Beyond Technical Analysis
More